Demant A/S (DEMANT.CO) Aktie Kurs

Demant A/S Kurs

OMX·LUKKET
345,20
​
Markedet lukket

Omsætningen er vokset med 8,3 % om året de seneste 19 år til 23,08 Mrd. DKK. Indtjening pr. aktie er vokset med 5,1 % om året de seneste 19 år. Demant A/Ss nettoavance ligger på 6,7 %, ned fra 13,7 % for flere år siden. Analytikernes mediankursmål er 265,20 DKK, hvilket er under den aktuelle kurs med 23,2 %. Af 26 analytikere anbefaler 15 køb — den samlede vurdering er Køb.

Demant A/S aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Demant A/S aktie og aktieanalyse

Demant A/S er et dansk selskab, der opererer inden for høreteknologi. Virksomheden blev grundlagt i 1904 og har hovedkvarter i Smørum, Danmark. Demant har flere datterselskaber i forskellige lande, herunder USA, Tyskland, Frankrig og Kina. Demants historie begynder med grundlæggelsen af selskabet Oticon af Hans Demant i København i 1904. Oticon var det første selskab, der fremstillede og solgte høreapparater. Siden da er virksomheden udviklet sig til en førende leverandør af høreapparater, cochleaimplantater og assistive lydanordninger. Demants forretningsmodel er baseret på udvikling og markedsføring af produkter inden for høreteknologi. Virksomheden er opdelt i flere forretningsområder, herunder høreapparater, cochleaimplantater samt diagnostik og forbrugsvarer. Inden for høreapparater tilbyder Demant et bredt udvalg af produkter, der er skræddersyet til forskellige kundegrupper. Tilbuddet spænder fra basis høreapparater til high-end-produkter med kunstig intelligens. Demants cochleaimplantatsystem er en banebrydende teknologi, der gør det muligt for døve eller hørehæmmede at høre. Det består af en implantiert enhed og en ekstern taleprocessor. Forretningsområdet diagnostik og forbrugsvarer hos Demant omfatter en række produkter, som sundhedsprofessionelle bruger til diagnosticering og behandling af høresygdomme. Disse inkluderer ørepropper, audiometri-enheder, tympanometri-enheder og andre. Demant er også aktivt inden for mange andre områder, herunder forskning, udvikling og produktion af produkter inden for høreteknologi. Virksomheden har et stærkt globalt netværk af partnere, distributører og kunder, hvilket yderligere styrker dens position som en førende leverandør af høreteknologiprodukter. Samlet set har Demant gennem sin engagement i excellence og innovation udviklet en dyb forståelse for behovene og kravene hos mennesker med hørenedsættelser. Med sit brede produktsortiment, globale netværk og store fokus på kundetilfredshed har Demant blevet et betroet navn inden for høreteknologi.

Hyppigt stillede spørgsmål om Demant A/S-aktien

The business model of Demant A/S is focused on providing innovative hearing healthcare solutions. Demant A/S operates through its four business segments - Hearing Devices, Diagnostic Instruments, Hearing Implants, and Personal Communication. With a strong emphasis on research and development, the company offers a wide range of hearing aids, wireless communication devices, and diagnostic instruments for better hearing and communication. Demant A/S aims to improve the quality of life for individuals with hearing loss by constantly striving to develop advanced and personalized solutions.

Demant A/S is primarily active in the healthcare industry, specifically focusing on hearing healthcare solutions. The company specializes in the development, manufacturing, and distribution of hearing aids, audiological diagnostics, and other hearing healthcare products. Demant A/S operates through various subsidiaries and brands, offering comprehensive solutions for individuals with hearing loss and professionals in the audiology field. With a strong presence in the global market, Demant A/S continues to innovate and provide cutting-edge technologies and services to improve the quality of life for those with hearing impairments.

The main competitors of Demant A/S in the market are Sonova Holding AG, William Demant Holding A/S, and GN Store Nord A/S.

Demant A/S, a leading global provider of hearing healthcare solutions, has a rich history and background. Established in 1904 in Denmark, Demant has consistently focused on innovation and advanced technology to improve the quality of life for people with hearing difficulties. With a strong emphasis on research and development, the company has been a pioneer in hearing aid technology, cochlear implants, and diagnostic equipment. Demant A/S operates through various well-known brands, including Oticon, Bernafon, and Sonic, offering a wide range of hearing solutions worldwide. With its commitment to excellence and customer satisfaction, Demant A/S continues to make significant contributions to the field of hearing healthcare.

Demant A/S, a renowned company in the stock market, has accomplished several significant milestones throughout its history. With a strong commitment to innovation and excellence, Demant A/S has achieved remarkable feats. Some notable milestones include the successful development and introduction of revolutionary hearing aid technologies, strategic acquisitions and partnerships, expanding its global presence, and consistently delivering exceptional financial performance. Demant A/S's dedication to providing cutting-edge solutions and improving the lives of individuals with hearing loss has solidified its position as a leader in the industry. With its continual progress and forward-thinking strategies, Demant A/S remains a force to reckon with in the stock market.

Demant A/S is primarily present in several countries and regions around the world. The company has a strong presence in North America, Europe, and the Asia Pacific region. In North America, Demant A/S operates through its subsidiary, Demant Inc., and has a significant market share in the hearing healthcare industry. In Europe, the company has a broad presence with operations in various countries including Denmark, Germany, and the United Kingdom. Additionally, Demant A/S has a growing presence in the Asia Pacific region, particularly in China and Australia. With its global footprint, Demant A/S serves customers and delivers innovative hearing solutions in multiple countries and regions.

Demant A/S represents a commitment to better hearing healthcare and enhanced communication. As a global leader in hearing healthcare solutions, Demant A/S places emphasis on innovation, research, and collaboration. The company strives to empower individuals with hearing loss through groundbreaking technology and personalized services. With a strong corporate philosophy focusing on transparency, integrity, and customer-centricity, Demant A/S aims to improve the quality of life for people with hearing challenges. With its comprehensive range of hearing devices, solutions, and support, Demant A/S is dedicated to enabling individuals to stay connected and engaged in their everyday lives.

Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 268,83 DKK for Demant A/S-aktien (median: 265,20 DKK), svarende til -22,1 % i forhold til seneste kurs. Konsensus bygger på 26 analytikervurderinger.

26 analytikere vurderer i øjeblikket Demant A/S-aktien: 15 anbefaler køb, 10 hold og 1 salg. For 2026 forventer analytikere, at Demant A/S genererer omsætning på 26,73 Mrd. DKK og indtjening pr. aktie på 15,07 DKK.

Omregnet til den aktuelle valutakurs handles Demant A/S-aktien til 46,18 EUR (345,20 DKK).

Demant A/S-aktien (DEMANT.CO) er noteret på 9 børser, herunder: London (0RGT.L), SIX (Zürich) (WDH.SW), Frankfurt (WDH1.F), München (WDH1.MU), Düsseldorf (WDH1.DU), Wien (DEMA.VI), Kopenhagen (DEMANT.CO).

The company Demant A/S is a Danish company specializing in the field of hearing aids and hearing technology. It has been a leading company in the audiology industry for many years and offers a wide range of products, from hearing aids to wireless communication systems. The core business of Demant A/S is the production of hearing aids. The company offers various models of hearing aids tailored to the individual needs of customers. Emphasis is placed on achieving the most natural sound quality possible in order to maximize comfort for the wearer. However, Demant A/S is not solely focused on hearing aids. The company also offers wireless communication systems and accessories designed to make everyday life easier for people with hearing problems. For example, there are various wireless products that allow people with hearing problems to enjoy high-quality sound while watching TV, listening to music, or making phone calls. Another important aspect of Demant A/S is otoplastics. These are individually customized hearing aids, often referred to as "custom-made," which are made by hearing aid acousticians. Otoplastics are frequently used in individuals with specific requirements for their hearing aids due to anatomical peculiarities or hearing loss. In recent years, Demant A/S has also focused on the field of digital health. This includes digital health solutions tailored to the individual needs of patients and customers, including apps that enable people with hearing problems to measure and monitor their hearing loss and adjust their hearing aids individually. Overall, Demant A/S has a broad business model that encompasses all areas of the audiology industry. The company offers a comprehensive portfolio of products and services that enable people with hearing problems to improve their quality of life. The focus is on providing individualized advice and support to customers in order to create the best possible customer loyalty. Due to the aging population and the increasing prevalence of hearing problems, experts predict that the market for hearing aids will continue to grow in the coming years. Demant A/S positions itself as a promising player in this market with its wide range of products and extensive industry experience.

forventet-omsætningen for Demant A/S er 26,73 Mrd. DKK. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

forventet-overskuddet for Demant A/S er 3,18 Mrd. DKK. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for Demant A/S er i øjeblikket 22,90. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Demant A/S-aktien.

Pris-til-salgs-forholdet (P/S) for Demant A/S er i øjeblikket 2,72. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Demant A/S-aktien.

AlleAktien-kvalitetsscore for Demant A/S er 8/10.

ISIN for Demant A/S er DK0060738599. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Demant A/S er A2AKB9. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Demant A/S er DEMANT.CO. Tickersymbolet bruges til at handle Demant A/S-aktier på børsen.

Fair værdiTerminal
289,97 DKK
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Sundhedsvæsens Udstyr & Forsyninger
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
1,50 Mio. DKK
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside demant.com
Land
Danmark
Valuta
DKK
Børsintroduktion
1. maj 1995
ISIN
DK0060738599
CUSIP
K3008M105
SEDOL
BZ01RF1
Markedsværdi
52-ugers interval
AAQS
8 / 10
PEG-forhold
4,53
P/E-forhold
P/Ee 2026
22,97
P/Ee 2027
19,82
P/Ee 2028
17,35
P/Ee 2029
15,90
P/Ee 2030
14,01
P/S
P/Se
2,72
EV/EBIT
23,42
K/B-forhold
7,41
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4,63 %
Sidst opdateret 22. nov. 2026, 12.42

Demant A/S Ticker

KØBENHAVN · DEMANT.COKØBENHAVN · DEMANT.CODÜSSELDORF · WDH1.DUFRANKFURT · WDH1.FLONDON · 0RGT.LMÜNCHEN · WDH1.MUOTC · WILLFSIX · WDH.SWWIEN · DEMA.VI

Demant A/S FIGI

DEMANT:DC · BBG000J940M0WDH1:GR · BBG000M42628WDH1:GF · BBG000M426D6WDH1:GD · BBG000M42860WDH1:GS · BBG000M428R7WDH1:GM · BBG000M42968WDH1:GB · BBG000M429W9WDH1:GI · BBG000M42BY2WILLF:US · BBG000PBDTM5WILLF:UV · BBG000PBF4B0DEMANC:IX · BBG000Q8SSB9WDH:EO · BBG000QW5DX0

Alle fundamentale data om Demant A/S i deep dive

Vores aktieanalyse af Demant A/S-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Demant A/S. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: